90 and 96% of patients had ACTH and cortisol measured following an overnight dexamethasone (2mg) suppression test (ON-DXMST) ( Figure 1 ). 75% of patients (n=24) that failed the ON-DXMST also had a low dose DXMST (0.5mg dexamethasone/6h/48h). Renin and aldosterone were measured in 80 and 88% of patients (Figure 2 ), and urine and or plasma metadrenalines were measured in 89% of patients ( Figure 3 ). Supine (n=13) and upright (n=84) renin activities were increased in 1 and 8 patients, respectively (Table 1) . Aldosterone concentrations were not increased in any of these patients. Aldosterone (upright measurement, n=91) was increased in one patient that did not have a suppressed renin activity.
32/97 patients failed to suppression cortisol <50nmol/L following an ON-DXMST (Table 1 ). 3/32 had normal urinary free cortisol results (<165nmol/24h). 24/32 also had a low dose DXMST. 23/24 failed to supress cortisol <50nmol/L. 1/24 also had a high dose DXMST (2mg DXMST every 6h/48h), which also failed to supress cortisol <50nmol/L. Using a cortisol concentration of ≥138nmol/L (3) as a cut off to diagnose subclinical Cushing's syndrome (SCS), 7.7% (n=8) of patients referred had SCS. 
